Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policies--as well as the involvement of numerous government agencies--affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.
Annetine C. Gelijns and Ethan A. Halm, Editors; Committee on Technological Innovation in Medicine, Institute of Medicine
1 Front Matter; 2 1. An Introduction to the Changing Economics of Technological Innovation in Medicine; 3 2. The Diffusion of New Technology: Costs and Benefits to Health Care; 4 3. The Changing Economics of Pharmaceutical Research and Development; 5 4. Public Policy and Access to New Drugs: The Case of Cancer Chemotherapy; 6 5. The Impact of Public Policy on Medical Device Innovation: A Case of Polyintervention; 7 6. The Dynamics of Medical Device Innovation: An Innovator's Perspective; 8 7. Reimbursement and the Dynamics of Surgical Procedure Innovation; 9 8. European Policies Influencing Pharmaceutical Innovation; 10 9. Medical Device Innovation and Public Policy in the European Economic Community; 11 10. Japan's Pharmaceutical Industry Postwar Evolution; 12 Appendix A: The Impact of Regulation and Reimbursement on Pharmaceutical Innovation; 13 Appendix B: The Economics of Pharmaceutical Research and Development: An Industry Persepective; 14 Appendix C: Contributors; 15 Index
Institute of Medicine, Committee on Quality of Health Care in America, Committee on Quality of Health Care in A, Institute Of Medicine, Molla S. Donaldson, Janet M. Corrigan, Linda T. Kohn
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual, Board on the Health of Select Population, Institute Of Medicine, Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities
Institute of Medicine, Committee for the Study of Health Consequences of the Stress of Bereavement, Committee for the Study of Health Conseq, Institute Of Medicine
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health, Board on Population Health and Public He, Institute Of Medicine
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Committee to Develop Methods Useful to t, Institute Of Medicine, Joseph Lipscomb
Institute of Medicine, Committee on Military Nutrition Research, Institute Of Medicine, Judith Grumstrup-Scott, Bernadette M. Marriott, Bernadette M Marriott